Our data support a dual-axis model in which a pharmacologic trigger interacts with modulation of the immune-tolerance threshold, suggesting that ICI exposure may lower immune tolerance and thereby amplify subsequent drug-induced, T cellmediated immune responses
Retatrutide Research# The pivotal Phase 2 trial (338 participants, NEJM 2023) showed 24.2% weight loss at 48 weeks
Not just the pain activities of daily living
The genome has between 20,000 and 25,000 protein-coding genes, while the genome of the bacterial community in the human intestine is approximately 9 million genes [31], capable of providing characteristics that the human genome does not possess
Coli species are common culprits in SIBO (small intestinal bacterial overgrowth) issues which I will discuss further in the next section
[Google Scholar] Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: A non-inferiority, randomised phase 3 trial